Compare SGHT & LAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGHT | LAW |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 235.0M | 274.2M |
| IPO Year | 2021 | 2021 |
| Metric | SGHT | LAW |
|---|---|---|
| Price | $4.99 | $3.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $9.08 | $8.00 |
| AVG Volume (30 Days) | 188.2K | ★ 548.7K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.16 | 22.58 |
| EPS | N/A | ★ N/A |
| Revenue | $77,363,000.00 | ★ $156,849,000.00 |
| Revenue This Year | $11.67 | $11.23 |
| Revenue Next Year | $10.39 | $10.60 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 8.29 |
| 52 Week Low | $3.11 | $2.45 |
| 52 Week High | $9.24 | $9.11 |
| Indicator | SGHT | LAW |
|---|---|---|
| Relative Strength Index (RSI) | 57.35 | 47.34 |
| Support Level | $4.86 | $3.81 |
| Resistance Level | $5.25 | $4.94 |
| Average True Range (ATR) | 0.40 | 0.34 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 57.24 | 27.41 |
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.